Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Parker, W.A.E."'
Autor:
Parker, W.A.E., Sagar, R., Kurdee, Z., Hawkins, F., Naseem, K.M., Grant, P.J., Storey, R.F., Ajjan, R.A.
Publikováno v:
Cardiovascular Diabetology
Background\ud \ud The enhanced thrombotic milieu in diabetes contributes to increased risk of vascular events. Aspirin, a key antiplatelet agent, has inconsistent effects on outcomes in diabetes and the best dosing regimen remains unclear. This work
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::3005abf5c68dcc2f19e69835d42006ca
https://eprints.whiterose.ac.uk/182266/1/s12933-021-01427-y.pdf
https://eprints.whiterose.ac.uk/182266/1/s12933-021-01427-y.pdf
Platelets participate centrally in atherothrombosis, resulting in vessel occlusion and ischaemia. Consequently, optimisation of antiplatelet regimens has the potential to further reduce the residual burden of morbidity and mortality associated with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::19596f250be7b41ece6a7011b57f398d
Autor:
Sumaya, W., Parker, W.A.E., Judge, H.M., Hall, I.R., Orme, R.C., Adam, Z., Richardson, J.D., Rothman, A.M.K., Morgan, K.P., Gunn, J.P., Storey, R.F.
A novel enoxaparin regimen consisting of intra-arterial bolus (0.75 mg/kg) followed by intravenous infusion (0.75 mg/kg/6 hours) has been developed as a possible solution to the delayed absorption of oral P2Y12 inhibitors in opiate-treated ST-elevati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::c1531ca5ecbe253bf674ecb0636fc851
Autor:
Parker, V.L., Winter, M.C., Whitby, E., Parker, W.A.E., Palmer, J.E., Tidy, J.A., Pacey, A.A., Hancock, B.W., Harrison, R.F.
Background\ud \ud The International Federation of Gynaecology and Obstetrics (FIGO) score identifies gestational trophoblastic neoplasia (GTN) patients as low- or high-risk of single-agent chemotherapy resistance (SACR). Computed tomography (CT) has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::4893e168b3199cc6ad86ca3be0592d0f
Autor:
Hennigan, B.W., Good, R., Adamson, C., Parker, W.A.E., Martin, L., Anderson, L., Campbell, M., Serruys, P.W., Storey, R.F., Oldroyd, K.G.
Cessation of one component of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) has been associated with increased risk of ischemic events but it is uncertain whether discontinuation of aspirin is preferable to disco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::31fdd0a0f3ba6457b555a1348e9dafde
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Parker, W.A.E., Orme, R.C., Hanson, J., Stokes, H.M., Bridge, C.M., Shaw, P.A., Sumaya, W., Thorneycroft, K., Petrucci, G., Porro, B., Judge, H.M., Ajjan, R.A., Rocca, B., Storey, R.F.
Higher aspirin doses may be inferior in ticagrelor-treated acute coronary syndrome (ACS) patients and reducing bleeding risk whilst maintaining antithrombotic benefits could improve outcomes. We characterized the pharmacodynamics of a novel dual-anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::92cc448dbb15d3271cb56562aa828d00